| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff56da6357e6d4fb1661d0a3049be2f0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6816 |
| filingDate |
2022-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25dad3b883c9cf9234352239cbc70a60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41640d2ceaaaa4f21458ff6f6fb06877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d112227f4159fb10a461fc2e32ebb237
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9cca2adfb0396da0196651aad0f2be4 |
| publicationDate |
2022-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022221581-A1 |
| titleOfInvention |
Programmable nucleases and methods of use |
| abstract |
The present disclosure provides compositions and methods of use for Type V CRISPR/Cas proteins. Type V CRISPR/Cas proteins may be configured to bind and modify nucleic acids in a sequence specific manner. |
| priorityDate |
2021-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |